BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38406915)

  • 1. Primary Ovarian Burkitts Lymphoma.
    Jan Z; Khan AU; Ilyas A; Faiz S
    J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S807-S809. PubMed ID: 38406915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
    Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
    Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.
    Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
    Crosswell HE; Bergsagel DJ; Yost R; Lew G
    Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt's lymphoma in a young Brazilian boy.
    Pereira CM; Lopes AP; Meneghini AJ; Silva GB; Monteiro MC; Botelho Tde L
    Malays J Pathol; 2010 Jun; 32(1):59-64. PubMed ID: 20614728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
    Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
    Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat Burkitt lymphoma in adults.
    Jacobson C; LaCasce A
    Blood; 2014 Nov; 124(19):2913-20. PubMed ID: 25258344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity.
    Jaradat JM; Potluri A; Bilodeau EA
    Indian J Dent Res; 2013; 24(3):384-6. PubMed ID: 24025890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
    Unholzer A; Starz H; Hirschsteiner O; Balda BR
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):46-51. PubMed ID: 16353750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
    Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
    Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.
    Zhang S; Wilson D; Czader M
    Ann Lab Med; 2015 Mar; 35(2):254-6. PubMed ID: 25729731
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
    Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.
    Ahn JY; Seo YH; Park PW; Kim KH; Park MJ; Jeong JH; Park SH; Song YH
    Ann Lab Med; 2012 Mar; 32(2):162-6. PubMed ID: 22389885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.
    Maruyama D; Watanabe T; Maeshima AM; Nomoto J; Taniguchi H; Azuma T; Mori M; Munakata W; Kim SW; Kobayashi Y; Matsuno Y; Tobinai K
    Int J Hematol; 2010 Dec; 92(5):732-43. PubMed ID: 21120644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary chest wall Burkitt lymphoma in a case of HIV infection with immune reconstitution.
    Jain A; Arun VA; Bal A; Malhotra P
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.